given my cognitive benefits continue, very positive on the results of the Ambroxol for PD dementia trial ending this year with findings to be published in 2022:
beyond that, it appears there is a similarly focused Norwegian trial in the planning stages as well:
https://alz-journals.onlinelibrary.wiley.com/doi/abs/10.1002/alz.042589